Zhejiang Shengda Bio-Pharm Co., Ltd. (603079.SS)

CNY 16.08

(0.06%)

Total Debt Summary of Zhejiang Shengda Bio-Pharm Co., Ltd.

  • Zhejiang Shengda Bio-Pharm Co., Ltd.'s latest annual total debt in 2023 was 238.44 Million CNY , up 611.01% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd.'s latest quarterly total debt in 2024 Q1 was 370.13 Million CNY , up 55.23% from previous quarter.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported annual total debt of 33.53 Million CNY in 2022, down -78.66% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported annual total debt of 157.17 Million CNY in 2021, up 36.4% from previous year.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported quarterly total debt of 240.02 Million CNY for 2024 Q3, down -21.91% from previous quarter.
  • Zhejiang Shengda Bio-Pharm Co., Ltd. reported quarterly total debt of 309.64 Million CNY for 2024 Q2, down -16.34% from previous quarter.

Annual Total Debt Chart of Zhejiang Shengda Bio-Pharm Co., Ltd. (2023 - 2012)

Historical Annual Total Debt of Zhejiang Shengda Bio-Pharm Co., Ltd. (2023 - 2012)

Year Total Debt Total Debt Growth
2023 238.44 Million CNY 611.01%
2022 33.53 Million CNY -78.66%
2021 157.17 Million CNY 36.4%
2020 115.22 Million CNY -67.1%
2019 350.25 Million CNY 155.0%
2018 137.35 Million CNY 128.92%
2017 60 Million CNY -35.14%
2016 92.5 Million CNY 105.56%
2015 45 Million CNY -59.18%
2014 110.25 Million CNY -12.33%
2013 125.75 Million CNY -2.37%
2012 128.8 Million CNY 0.0%

Peer Total Debt Comparison of Zhejiang Shengda Bio-Pharm Co., Ltd.

Name Total Debt Total Debt Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 1.58 Billion CNY 84.937%
Yabao Pharmaceutical Group Co., Ltd 209 Million CNY -14.086%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 15.79 Billion CNY 98.49%
Harbin Pharmaceutical Group Co., Ltd. 3.55 Billion CNY 93.3%
Tasly Pharmaceutical Group Co., Ltd 2.95 Billion CNY 91.943%
Zhejiang Medicine Co., Ltd. 801.44 Million CNY 70.249%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 839.84 Million CNY 71.609%
Lionco Pharmaceutical Group Co.,Ltd. 565.61 Million CNY 57.844%
Humanwell Healthcare (Group) Co.,Ltd. 9.94 Billion CNY 97.603%
Ginwa Enterprise (Group) Inc. 10.77 Million CNY -2112.691%
Joincare Pharmaceutical Group Industry Co.,Ltd. 7.4 Billion CNY 96.779%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 175.68 Million CNY -35.719%
China Animal Husbandry Industry Co., Ltd. 1.45 Billion CNY 83.625%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 9.91 Million CNY -2306.045%
Zhejiang Huahai Pharmaceutical Co., Ltd. 7.45 Billion CNY 96.8%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.08 Billion CNY 77.975%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.3 Billion CNY 81.693%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 727.9 Million CNY 67.243%
Chongqing Taiji Industry(Group) Co.,Ltd 4.86 Billion CNY 95.095%
HPGC Renmintongtai Pharmaceutical Corporation 2.33 Billion CNY 89.78%
Nanjing Well Pharmaceutical Group Co.,Ltd. 486.95 Million CNY 51.035%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 995.24 Million CNY 76.042%
Henan Lingrui Pharmaceutical Co., Ltd. 149.26 Million CNY -59.742%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.2 Billion CNY 80.192%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.07 Billion CNY 77.904%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 48.13 Million CNY -395.359%
Zhongzhu Healthcare Holding Co.,Ltd 23.94 Million CNY -895.916%
Beijing Tongrentang Co., Ltd 3.42 Billion CNY 93.042%
KPC Pharmaceuticals, Inc. 1.17 Billion CNY 79.642%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 17.28 Million CNY -1279.729%
North China Pharmaceutical Company Ltd. 11.72 Billion CNY 97.967%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 462.87 Million CNY 48.487%
Tibet Weixinkang Medicine Co., Ltd. 7.68 Million CNY -3003.839%
China National Medicines Corporation Ltd. 3.15 Billion CNY 92.449%
Zhejiang Hisun Pharmaceutical Co., Ltd. 5.69 Billion CNY 95.811%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.15 Billion CNY 92.432%
ChengDu ShengNuo Biotec Co.,Ltd. 267.22 Million CNY 10.77%
Dali Pharmaceuticalco.,Ltd 23.66 Million CNY -907.674%
Changchun BCHT Biotechnology Co. 20.47 Million CNY -1064.718%
Shanghai Jiaoda Onlly Co.,Ltd 208.92 Million CNY -14.126%
Jiang Zhong Pharmaceutical Co.,Ltd 56.62 Million CNY -321.097%
Mayinglong Pharmaceutical Group Co., LTD. 380.42 Million CNY 37.322%
Cisen Pharmaceutical Co., Ltd. 170.67 Million CNY -39.705%
Hunan Warrant Pharmaceutical Co.,Ltd 24.18 Million CNY -886.049%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 35.72 Billion CNY 99.333%
Jianmin Pharmaceutical Group Co.,Ltd. 501.17 Million CNY 52.424%
Hunan Fangsheng Pharmaceutical Co., Ltd. 679.7 Million CNY 64.92%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 1.78 Billion CNY 86.646%
Guobang Pharma Ltd. 963.26 Million CNY 75.247%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 659.05 Million CNY 63.821%
Kangmei Pharmaceutical Co., Ltd. 255.01 Million CNY 6.499%
Shandong Buchang Pharmaceuticals Co., Ltd. 3.4 Billion CNY 93.006%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.19 Billion CNY 92.529%
Henan Taloph Pharmaceutical Stock Co.,Ltd 819.3 Million CNY 70.897%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 116.7 Million CNY -104.309%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 2.62 Billion CNY 90.919%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 446.65 Million CNY 46.616%
Shanghai Shyndec Pharmaceutical Co., Ltd. 1.75 Billion CNY 86.375%
Shanghai Yizhong Pharmaceutical Co., Ltd. 44.02 Million CNY -441.567%
Tibet Rhodiola Pharmaceutical Holding Co. 501.52 Million CNY 52.456%
Sichuan Huiyu Pharmaceutical Co., Ltd. 435.5 Million CNY 45.249%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 443.84 Million CNY 46.278%
CanSino Biologics Inc. 2.71 Billion CNY 91.217%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 705.78 Million CNY 66.216%
Shandong Lukang Pharmaceutical Co.,Ltd. 3.43 Billion CNY 93.059%